Good afternoon and welcome to the Full Year and Fourth Quarter 2024 Financial Results Conference Call for Verb Technology Company, Incorporated. At this time, all participants are in a listen-only ...

IN an uncertain world, a key priority for Singapore is to develop and grow local ventures into leading companies. Female-led ...

ORIC-944, a PRC2 inhibitor with best-in-class properties, restores luminal features and restricts adaptation in prostate cancer models, conferring synergy with AR pathway inhibitors ORIC-944 is a ...

Central bank digital currencies would destroy any chance for financial privacy, but society is willingly moving in that ...

Update on IND-enabling data for MP0712, a Radio-DARPin targeting DLL3 and labeled with 212Pb, co-developed with Orano Med; entering FIH studies in 2025 for the treatment of small cell lung cancer Firs ...

Acquired In-Process Research and Development expense: Acquired in-process research and development expense was $51.7 million ...

Alphawave Semi (LSE: AWE), maker of connectivity and compute silicon for technology infrastructure, has announced its portfolio of optoelectronics products addressing the high-speed interconnect ...

Several ASX healthcare companies are leading the charge in finding new treatments for complex neurological disorders. ... Read More The post Top of mind: ASX companies tackling neurological disorders ...

Both TB treatment and TB preventive therapy involve taking lots of pills, usually for several months. Researchers are working ...

Getz goes into his second full season with no money to spend and no hope for the present, and yet he’s optimistic.

This has had interesting effects on the C-suite and resulted in the creation of a brand-new portfolio: the Chief Monetisation ...

Joining us today are Oncocyte President and CEO, Josh Riggs; Chief Science Officer, Ekke Schutz; and CFO, Andrea James. We ...